The PsyIndex rose just over four percent last week, extending the industry’s rally from the prior week. Delic Corp. (CSE: DELC) was also added to the PsyIndex following its recent public listing.
Top Gainers
|
Top Decliners
|
Corporate News, Deals & Listings
- Lobe Sciences Inc. (CSE: LOBE) announced the launch of a pre-clinical study in collaboration with the University of Miami. via CannabisFN
- Lobe Sciences Inc. (CSE: LOBE) announced the C$23M sales of Cowlitz Cannabis option to Ionic Brands Corp. via CannabisFN
- Lobe Sciences Inc. (CSE: LOBE) began the engineering of its nasal mist device. via CannabisFN
- Entheon Biomedical Corp. (CSE: ENBI) annoucned a CRO agreement for its Phase 1 clinical trial to start in 2021. via CannabisFN
- Nova Mentis Life Science Corp. (CSE: NOVA) completed the acquisition of Pilz Bioscience. via CannabisFN
- Field Trip Health Ltd. (CSE: FTRP) announced its second quarter financial results. via CannabisFN
- Field Trip Health Ltd. (CSE: FTRP) provided an operational and investor update. via CannabisFN
- Pure Extracts Inc. (CSE: PULL) collaborates with Dr. Alexander MacGregor on mushroom formulation. via CannabisFN
- Mind Cure Health Inc. (CSE: MCUR) promotes Kelsey Ramsden to President & CEO. via CannabisFN
- Havn Life Sciences Inc. (CSE: HAVN) attracts policy expert and joins UK policy reform group. via CannabisFN
- PharmaTher (CSE: PHRM) expands partnership with University Health Network for platform development. via CannabisFN
- Numinus Wellness Inc. (TSX-V: NUMI) and MAPS announce collaboration agreement to seek approval for trial. via CannabisFN
- Entheon Biomedical Corp. (CSE: ENBI) announced several corporate updates including a new investment. via CannabisFN
- Havn Life Sciences Inc. (CSE: HAVN) partnered with a veterans mental health nonprofit. via CannabisFN
- PsyBio Therapeutics Inc. closed an oversubscribed private placement of C$14.5 million. via CannabisFN
- Nova Mentis Life Science Corp. (CSE: NOVA) appointed Dr. Marvin S. Hausman as Chairman of its advisory board. via CannabisFN
- Cybin Corp. (NEO: CYBN) signed a definitive agreement to acquire Adelia Therapeutics. via CannabisFN
Featured Content
Pure Extracts Unveils Plans for Functional Mushrooms
Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) has recognized these trends and begun to expand its business model to include mushroom formulations through the use of extraction processes that have proven compatible with its existing infrastructure.
We take a closer look at these plans and why investors should pay close attention.
Industry Developments
- The UK government is poised to receive a seven-figure payout via a psychedelics investment. via Financial Times
Billionaire investors are investing heavily in the psychedelics boom. via BayStreet
